PCSS and The Office-Based Treatment of Opioid Dependence (Waiver Eligibility Training)
PCSS is made up of a coalition of 23 leading national organizations representing healthcare providers and other key stakeholders who are working on the front lines of the opioid crisis.
Training is available for those interested in seeking their waiver to prescribe buprenorphine in the treatment of opioid addiction. Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course.
To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training.
The AOAAM uses the Half-and-Half format where 4.25-hours of either a face-to-face training with an instructor or 4.25-hours of a live webcast training with an instructor make up the first half of the training and a 3.75-hour computer-based self-study make up the second half for a combined total of 8-hours of training.
2nd Half of the Course
The combined online computer-study and face-to-face/or live webcast training provides physicians the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorder. It also provides NPs and PAs the 8-hours of training to be applied toward their 24-hours of required training time. NPs and PAs will be required to train for an additional 16 hours before they are eligible to apply for the waiver. SAMHSA offers this training for free. Click here for info: NPs and PAs - Additional 16-hour Component
Continuing Medical Education
8-Hour Training - Face-to-Face Format
Program Goals and Objectives
1.) Maintain and expand a comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder.
The content of educational resources is overseen by a panel of experienced clinicians, researchers, and educators forming a Clinical Expert Panel.
2.) Expand existing clinical mentoring program to provide guidance to prescribers and key health professionals on prevention, identification, and treatment of opioid use disorder.
For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers' Clinical Support System (PCSS) visit pcssNOW.org.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Latest News read more